Hee-Weon Lee
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
-
- Phytochemicals and Antioxidant Activities
Papers in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
- IL-33, ST2, and ILC Pathways 2
-
- Advanced Glycation End Products research 6
- Co-authors
- Suhkneung Pyo (10 shared papers)Dong‐Kwon Rhee (3 shared papers)Byung-Oh Kim (2 shared papers)Sang Keun Ha (9 shared papers)Sung Hee Um (2 shared papers)Yoonsook Kim (7 shared papers)In‐Wook Choi (5 shared papers)Min Ji Gu (7 shared papers)
- Journals
- The FASEB Journal (2 papers)Chemico-Biological Interactions (2 papers)Antioxidants (2 papers)International Immunopharmacology (1 paper)Current Issues in Molecular Biology (1 paper)
- Partner nations
- South KoreaUnited StatesAustralia
In The Last Decade
Hee-Weon Lee
19 papers receiving 319 citations
Peers
Comparison fields: 5 of 70
- Clinical Biochemistry 32
- Biochemistry 29
- Geriatrics and Gerontology 10
- Pharmacology 21
- Complementary and alternative medicine 19
Countries citing papers authored by Hee-Weon Lee
This map shows the geographic impact of Hee-Weon Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hee-Weon Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hee-Weon Lee more than expected).
Fields of papers citing papers by Hee-Weon Lee
This network shows the impact of papers produced by Hee-Weon Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hee-Weon Lee. The network helps show where Hee-Weon Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Hee-Weon Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 53 | |
| 2 | 2018 | 50 | |
| 3 | 2018 | 40 | |
| 4 | 2015 | 28 | |
| 5 | 2021 | 21 | |
| 6 | 2017 | 19 | |
| 7 | 2017 | 19 | |
| 8 | 2017 | 15 | |
| 9 | 2022 | 14 | |
| 10 | 2018 | 12 | |
| 11 | 2020 | 12 | |
| 12 | 2022 | 12 | |
| 13 | 2014 | 9 | |
| 14 | 2023 | 8 | |
| 15 | 2023 | 6 | |
| 16 | 2021 | 3 | |
| 17 | 2022 | 1 | |
| 18 | 2014 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2022 | 0 |
About Hee-Weon Lee
Hee-Weon Lee is a scholar working on Immunology, Clinical Biochemistry, Molecular Biology, Cancer Research and Surgery, having authored 20 papers that have together received 324 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (6 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Cancer, Lipids, and Metabolism (2 papers), Cholesterol and Lipid Metabolism (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Adipose Tissue and Metabolism (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). The work is most often cited by research in Clinical Biochemistry (32 citations), Biochemistry (29 citations), Geriatrics and Gerontology (10 citations), Pharmacology (21 citations) and Complementary and alternative medicine (19 citations). Hee-Weon Lee has collaborated with scholars based in South Korea, United States and Australia. Frequent co-authors include Suhkneung Pyo, Dong‐Kwon Rhee, Byung-Oh Kim, Sang Keun Ha, Sung Hee Um, Yoonsook Kim, In‐Wook Choi, Min Ji Gu, Dong Kwon Rhee and Jin‐Wook Kim. Their work appears in journals such as The FASEB Journal, Chemico-Biological Interactions, Antioxidants, International Immunopharmacology and Current Issues in Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.